Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase
about
p38γ and p38δ Mitogen Activated Protein Kinases (MAPKs), New Stars in the MAPK GalaxyNF-κB, the first quarter-century: remarkable progress and outstanding questionsTumor progression locus 2 (Tpl2) kinase as a novel therapeutic target for cancer: double-sided effects of Tpl2 on cancerImplication of inflammatory signaling pathways in obesity-induced insulin resistanceQuantitative modeling of dose–response and drug combination based on pathway networkNF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic ImplicationsMAP3K8/TPL-2/COT is a potential predictive marker for MEK inhibitor treatment in high-grade serous ovarian carcinomasCausal Modeling of Cancer-Stromal Communication Identifies PAPPA as a Novel Stroma-Secreted Factor Activating NFκB Signaling in Hepatocellular CarcinomaCot/tpl2 participates in the activation of macrophages by adiponectin.The linear ubiquitin chain assembly complex regulates TRAIL-induced gene activation and cell death.TPL2 kinase regulates the inflammatory milieu of the myeloma nicheTPL2 mediates autoimmune inflammation through activation of the TAK1 axis of IL-17 signaling.Macrophages in multiple myeloma: emerging concepts and therapeutic implications.Resveratrol prevents tumorigenesis in mouse model of Kras activated sporadic colorectal cancer by suppressing oncogenic Kras expression.MAP3K8 (TPL2/COT) affects obesity-induced adipose tissue inflammation without systemic effects in humans and in mice.Pharmacological inhibition of TPL2/MAP3K8 blocks human cytotoxic T lymphocyte effector functions.Tumor progression locus 2 differentially regulates IFNγ and IL-17 production by effector CD4+ T cells in a T cell transfer model of colitisToll-like receptor 2-dependent extracellular signal-regulated kinase signaling in Mycobacterium tuberculosis-infected macrophages drives anti-inflammatory responses and inhibits Th1 polarization of responding T cellsTumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple MyelomaTPL-2 Regulates Macrophage Lipid Metabolism and M2 Differentiation to Control TH2-Mediated Immunopathology.p38γ and p38δ kinases regulate the Toll-like receptor 4 (TLR4)-induced cytokine production by controlling ERK1/2 protein kinase pathway activationCot/tpl2-MKK1/2-Erk1/2 controls mTORC1-mediated mRNA translation in Toll-like receptor-activated macrophagesCoordinate regulation of TPL-2 and NF-κB signaling in macrophages by NF-κB1 p105.p97/VCP promotes Cullin-RING-ubiquitin-ligase/proteasome-dependent degradation of IκBα and the preceding liberation of RelA from ubiquitinated IκBα.MAP3K8 kinase regulates myeloma growth by cell-autonomous and non-autonomous mechanisms involving myeloma-associated monocytes/macrophages.Distinct NF-κB and MAPK Activation Thresholds Uncouple Steady-State Microbe Sensing from Anti-pathogen Inflammatory Responses.Tpl2 inhibitors thwart endothelial cell function in angiogenesis and peritoneal dissemination.Tumor progression locus 2 reduces severe allergic airway inflammation by inhibiting Ccl24 production in dendritic cells.Regulation of experimental autoimmune encephalomyelitis by TPL-2 kinase.IκB kinase regulation of the TPL-2/ERK MAPK pathway.New insight into the oncogenic mechanism of the retroviral oncoprotein Tax.Tpl2 promotes innate cell recruitment and effector T cell differentiation to limit Citrobacter rodentium burden and dissemination.TPL-2 restricts Ccl24-dependent immunity to Heligmosomoides polygyrus.Insights into the inhibition and mechanism of compounds against LPS-induced PGE2 production: a pathway network-based approach and molecular dynamics simulations.Physical and functional interaction of the TPL2 kinase with nucleophosmin.Separation of zinc-dependent and zinc-independent events during early LPS-stimulated TLR4 signaling in macrophage cells.IL-17 Signaling: The Yin and the Yang.Tpl2 promotes neutrophil trafficking, oxidative burst, and bacterial killing.Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.The Tpl2 Kinase Regulates the COX-2/Prostaglandin E2 Axis in Adipocytes in Inflammatory Conditions.
P2860
Q26752327-E2196A54-89AA-461B-9C11-532F0B8B8502Q26822516-48772647-16A4-4861-A569-9A4E1AA5F08FQ27021391-513A92C8-FD27-49C1-AF1C-D294F69259A5Q27500365-5994A305-68DB-4958-A344-36F0F3748720Q27902294-A26CB985-FC14-44C6-8182-834E903F0633Q28078299-E5619D74-65AA-41AC-8E6E-B03FB7FE7399Q28393224-6402797C-BB8A-4668-9FD2-5FADC373A43CQ28547556-B4A489AB-8876-4E66-A064-1359638EBBCDQ33613182-88A644A3-6649-4397-8E69-C263E57E0D0EQ33625907-3C1C23AA-331D-48DB-B0C4-9CE5AB8D6249Q33714724-9B5FEC68-18ED-48C3-9E92-E45A0348EFB7Q33964282-B2E62599-41B6-4FA6-BB17-FE072815BE27Q34329242-D43A4316-1369-4950-BAD1-D5D8EC5CE207Q34586249-CD51C705-1657-466A-9841-3B73BB9D6869Q35107734-595BFD21-45C5-49DF-9ED6-D8829E60EEFEQ35124167-806EC600-47DC-4ACC-8679-76DA207F81ADQ35187958-F7A55565-9236-4A9A-8002-7686A10FB7C6Q35609316-75A519E4-3E09-4129-B316-346D864ABFD1Q35925252-9E09A75C-15D0-4537-A1E3-511F95215E33Q36093909-BEFB5253-FC52-4143-A1BF-C469D080372CQ36094132-EFB21313-CB1B-4D09-8B57-36E1D86F629BQ36128003-F48AAFF5-A2ED-4B16-8809-18C4CBD395A2Q36172865-8F6B1FB4-7E31-4195-9224-98672C28E128Q36476873-7CFCE79D-6AA7-4DDC-A38E-85D78A4B2DD5Q36674532-0E9B262D-B31F-4CA5-9288-C6448ED946C9Q37033724-9A0901B4-8BCD-4BD6-9E59-89ECB9DC28EEQ37162383-6401542C-F5A0-4415-8E32-1204A28978E1Q37626144-96C189B3-66E7-49E4-9BE0-B2892AA0B7B6Q37692262-7AC17468-DE1F-4911-A848-392481206219Q37995683-2A3C6E0B-B2B8-4FB2-B20F-68D545ADCA51Q38032236-177BB1A1-9609-4E1A-A50B-2DC7FC999DD8Q38650821-748C4429-A231-456D-B4F5-E014D707D903Q38651585-82E316AA-0FB6-41A4-8FE9-5E9AD3915648Q38955892-AEA46ADD-3C8B-474B-A5E1-0FA51A96B99BQ38977653-B84BB86E-7DE9-4505-BA95-CF7F29A4C900Q38986704-B826E30C-C785-4100-915E-4CABC11A9177Q39158530-0A8E146C-CCBC-4896-A850-A51C3562B916Q40273190-F707EEF8-3805-4BE0-BF9B-53FB02561C8BQ40645815-2B9C18A8-7F11-46DF-AD85-21DB6E16F779Q40893687-2A116314-634A-4A1F-9058-20406993807F
P2860
Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase
@ast
Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase
@en
Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase
@nl
type
label
Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase
@ast
Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase
@en
Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase
@nl
prefLabel
Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase
@ast
Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase
@en
Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase
@nl
P2093
P2860
P3181
P356
P1433
P1476
Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase
@en
P2093
Srividya Sriskantharajah
Steven C Ley
Thorsten Gantke
P2860
P2888
P304
P3181
P356
10.1038/CR.2010.173
P407
P577
2011-01-01T00:00:00Z